1. Home
  2. NAMS vs MBC Comparison

NAMS vs MBC Comparison

Compare NAMS & MBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • MBC
  • Stock Information
  • Founded
  • NAMS 2019
  • MBC 1954
  • Country
  • NAMS Netherlands
  • MBC United States
  • Employees
  • NAMS N/A
  • MBC N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • MBC Agricultural Chemicals
  • Sector
  • NAMS Health Care
  • MBC Industrials
  • Exchange
  • NAMS Nasdaq
  • MBC Nasdaq
  • Market Cap
  • NAMS 2.3B
  • MBC 2.3B
  • IPO Year
  • NAMS N/A
  • MBC N/A
  • Fundamental
  • Price
  • NAMS $20.12
  • MBC $16.72
  • Analyst Decision
  • NAMS Strong Buy
  • MBC Strong Buy
  • Analyst Count
  • NAMS 6
  • MBC 1
  • Target Price
  • NAMS $33.80
  • MBC $23.00
  • AVG Volume (30 Days)
  • NAMS 634.7K
  • MBC 856.5K
  • Earning Date
  • NAMS 11-06-2024
  • MBC 11-05-2024
  • Dividend Yield
  • NAMS N/A
  • MBC N/A
  • EPS Growth
  • NAMS N/A
  • MBC N/A
  • EPS
  • NAMS N/A
  • MBC 1.14
  • Revenue
  • NAMS $33,594,000.00
  • MBC $2,709,800,000.00
  • Revenue This Year
  • NAMS N/A
  • MBC $2.41
  • Revenue Next Year
  • NAMS N/A
  • MBC $7.56
  • P/E Ratio
  • NAMS N/A
  • MBC $14.71
  • Revenue Growth
  • NAMS 78.77
  • MBC N/A
  • 52 Week Low
  • NAMS $8.90
  • MBC $13.16
  • 52 Week High
  • NAMS $26.35
  • MBC $20.67
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 44.60
  • MBC 41.52
  • Support Level
  • NAMS $19.59
  • MBC $16.37
  • Resistance Level
  • NAMS $25.32
  • MBC $17.09
  • Average True Range (ATR)
  • NAMS 1.44
  • MBC 0.76
  • MACD
  • NAMS -0.32
  • MBC -0.11
  • Stochastic Oscillator
  • NAMS 36.35
  • MBC 8.02

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About MBC MasterBrand Inc.

MasterBrand Inc operates as a residential cabinet manufacturer in North America. It offers a comprehensive portfolio of residential cabinetry products for the kitchen, bathroom, and other parts of the home. The firm sells its products throughout the United States and Canada through three primary channels: dealers, retailers, and builders.

Share on Social Networks: